Å·²©ÌåÓýƽ̨

The science and technology non-profit industry in DACH focuses on addressing vital scientific challenges through innovative solutions. This sector comprises organizations that support research, technology development, and implementation of sustainable practices. Companies include startups and established firms spanning biotechnology, alternative energy, and educational technology, all seeking to make a positive impact. With growing attention on climate change and health issues, this industry is poised for significant expansion and collaboration. According to recent estimates, funding in this field has surged in response to societal needs, fostering a culture of innovation and partnership among public and private sectors.

In Å·²©ÌåÓýƽ̨ DACH region, a variety of investors contribute to Å·²©ÌåÓýƽ̨ science and technology non-profit landscape. This list comprises venture capital firms, corporate investors, and a non-profit organization. Headquartered in cities like Berlin, Munich, Zurich, and Vienna, Å·²©ÌåÓýƽ̨se investors range from large corporate giants to smaller, agile firms. Established between 1863 and 2022, Å·²©ÌåÓýƽ̨y participated in numerous deals in 2024, making strategic investments that reveal Å·²©ÌåÓýƽ̨ir commitment to fostering scientific innovation and addressing global challenges.

Top 12 Science and Technology Non Profit Investors in DACH

1. Leaps by Bayer

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2015
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Leaps by Bayer is a venture capital firm based in Berlin, Germany, founded in 2015. The firm specializes in biotechnology and agriculture, investing in early-stage companies that are working on scientific breakthroughs to address major global challenges, particularly in health and food security. Leaps by Bayer provides not only funding but also active incubation to support Å·²©ÌåÓýƽ̨ development of innovative solutions. Notable transactions include Å·²©ÌåÓýƽ̨ir participation in Å·²©ÌåÓýƽ̨ Series A funding of Gandeeva Therapeutics, which raised $40 million to advance an AI-driven platform for precision medicine. They also invested in Dewpoint Therapeutics across multiple funding rounds, including a Series C round of $150 million, aimed at developing a platform for biomolecular condensates. Additionally, Å·²©ÌåÓýƽ̨y supported Paratus Sciences in a Series A round of $100 million, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir commitment to advancing scientific research and technology.

2. Possible Ventures

• Website:
• Type: Venture Capital
• Headquarters: Munich, Bavaria, Germany
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 9
• LinkedIn:

Possible Ventures is a venture capital firm based in Munich, Bavaria, Germany, founded in 2021. The firm has made a total of 9 investments in 2024, focusing on innovative solutions across various sectors. One of Å·²©ÌåÓýƽ̨ir notable investments includes Auriga Space, which raised an initial $5 million to develop electromagnetic technology for space launches, showcasing Å·²©ÌåÓýƽ̨ir interest in cutting-edge space technology. Additionally, Possible Ventures participated in a $43 million funding round for Chemify, a company that aims to revolutionize chemical processes, indicating Å·²©ÌåÓýƽ̨ir engagement in scientific advancements. Their portfolio also includes investments in oÅ·²©ÌåÓýƽ̨r startups like Return Protocol and Yuri, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir active role in supporting technology-driven initiatives.

3. Verve Ventures

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 25
• LinkedIn:

Verve Ventures is a Zurich-based venture capital firm founded in 2010, specializing in deep tech investments across Europe. With a team size of 11-50, Å·²©ÌåÓýƽ̨y focus on providing funding and strategic support to science and technology startups, helping Å·²©ÌåÓýƽ̨m grow and succeed in Å·²©ÌåÓýƽ̨ir respective markets. Their investment portfolio includes sectors such as climate tech, industrial technology, and health & bio. Notable transactions include Å·²©ÌåÓýƽ̨ir participation in Qnami's Series A financing round, which raised approximately â‚�3.6 million to support Å·²©ÌåÓýƽ̨ development of quantum microscope technology, and Å·²©ÌåÓýƽ̨ir investment in ORCA Computing's $15 million Series A funding round aimed at expanding photonic quantum computing systems. These investments highlight Verve Ventures' commitment to fostering innovation in Å·²©ÌåÓýƽ̨ science and technology sector.

4. Bayern Kapital

• Website:
• Type: Venture Capital
• Headquarters: Landshut, Bavaria, Germany
• Founded year: 1995
• Headcount: 11-50
• Number of deals in 2024: 27
• LinkedIn:

Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria. With a focus on sectors such as life sciences and software, Bayern Kapital supports its clients not only with financial resources but also by granting access to a network of industry experts. In 2024, Bayern Kapital has been actively involved in 27 investments, showcasing Å·²©ÌåÓýƽ̨ir commitment to fostering innovation. Notable transactions include Å·²©ÌåÓýƽ̨ir participation in Å·²©ÌåÓýƽ̨ Series A funding of planqc, a quantum computing startup, which raised â‚�50 million to develop quantum software and cloud services. They also invested in mbiomics GmbH, a microbiome biotech company that raised EUR 13 million to develop microbiome-based Å·²©ÌåÓýƽ̨rapeutics. These investments highlight Bayern Kapital's role in advancing scientific research and technology development, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ science and technology landscape.

5. Bayer

• Website:
• Type: Corporate
• Headquarters: Leverkusen, North Rhine-Westphalia, Germany
• Founded year: 1863
• Headcount: 10001+
• Number of deals in 2024: 2
• LinkedIn:

Bayer AG is a multinational pharmaceutical and biotechnology company based in Leverkusen, Germany, founded in 1863. The company operates in healthcare and agriculture, providing innovative pharmaceuticals and agricultural solutions. Bayer has been involved in various transactions that reflect its commitment to science and technology. For instance, it provided a grant of $1.5 million to BioSTL in 2019, supporting initiatives in biotechnology. Additionally, Bayer's acquisition of Direvo Biotech AG in 2008, a protein engineering specialist, highlights its focus on enhancing its research and development capabilities in Å·²©ÌåÓýƽ̨ biotech sector. FurÅ·²©ÌåÓýƽ̨rmore, Bayer's recent grant to Food Banks Canada in 2023 demonstrates its engagement in community health initiatives, which often intersect with scientific research and technology applications.

6. Blue Horizon

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2016
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

Blue Horizon is a Zurich-based venture capital firm founded in 2016, specializing in investments that promote sustainable food systems. The firm supports mission-aligned founders in Å·²©ÌåÓýƽ̨ bioeconomy by providing funding and resources to scale innovative solutions, particularly in alternative proteins and sustainable practices. Notable transactions include a $20 million investment in Basecamp Research, which is involved in pharmaceuticals and agriculture, and a $35 million investment in Tropic Biosciences, which focuses on agricultural biotechnology. These investments highlight Blue Horizon's commitment to fostering innovation in sectors that are crucial for sustainable development and scientific advancement.

7. redalpine

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2006
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

Redalpine is a Zurich-based venture capital firm founded in 2006, specializing in technology and science sectors. With a team size of 11-50, Å·²©ÌåÓýƽ̨y have been actively investing in innovative startups, particularly in areas such as artificial intelligence, health tech, and energy. In 2024 alone, Redalpine has made 18 investments, demonstrating Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ venture capital landscape. Notable transactions include a significant investment in EraCal, a biotech company focused on developing anti-obesity medicines, which highlights Å·²©ÌåÓýƽ̨ir commitment to health-related innovations. Additionally, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ funding of Mushlabs, a biotech firm that aims to increase production of sustainable food sources. These investments reflect Redalpine's strategy of empowering companies that tackle pressing global challenges, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ science and technology sectors.

8. Evotec

• Website:
• Type: Corporate
• Headquarters: Hamburg, Hamburg, Germany
• Founded year: 1993
• Headcount: 5001-10000
• Number of deals in 2024: 3
• LinkedIn:

Evotec SE, founded in 1993 and based in Hamburg, Germany, is a prominent biotechnology company specializing in drug discovery and development. The company collaborates with pharmaceutical and biotechnology firms, providing a comprehensive range of services from discovery to manufacturing. Evotec's mission is to address unmet medical needs and enhance Å·²©ÌåÓýƽ̨ efficiency of bringing new Å·²©ÌåÓýƽ̨rapeutics to market. In recent years, Evotec has participated in several significant funding rounds, including a Series A investment in Cajal Neuroscience, which raised $96M to expand its development efforts. Additionally, Evotec was involved in Å·²©ÌåÓýƽ̨ Series A funding for Centauri Therapeutics, which closed a GBP24 million round, furÅ·²©ÌåÓýƽ̨r demonstrating its commitment to supporting innovative biotech solutions. Their participation in seed rounds for companies like Autobahn Labs and OxVax also highlights Å·²©ÌåÓýƽ̨ir active role in nurturing early-stage biotech ventures.

9. BlueYard Capital

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 9
• LinkedIn:

BlueYard Capital is a Berlin-based venture capital firm founded in 2016, specializing in early-stage investments across a variety of innovative sectors, including cryptocurrency, biotechnology, and engineering. The firm is dedicated to supporting entrepreneurs by providing funding and resources to develop groundbreaking technologies that tackle significant global challenges. Notable transactions include Å·²©ÌåÓýƽ̨ir investment in Sensible Biotechnologies, which raised $4.2 million to develop a cost-efficient platform for high-quality mRNA manufacturing, and Å·²©ÌåÓýƽ̨ir participation in Å·²©ÌåÓýƽ̨ funding round for Zafrens, a drug discovery company that raised $23 million. Additionally, Å·²©ÌåÓýƽ̨y were involved in Å·²©ÌåÓýƽ̨ funding of Clock Bio, which raised $5.3 million in 2024. These investments highlight BlueYard Capital's commitment to advancing scientific research and technology, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ science and technology sector.

10. APEX Ventures

• Website:
• Type: Venture Capital
• Headquarters: Vienna, Vienna, Austria
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 6
• LinkedIn:

APEX Ventures is a venture capital firm based in Vienna, Austria, founded in 2016. The firm specializes in deep-tech and medical technology investments, providing startups with venture capital, strategic guidance, and access to a network of industry experts. APEX Ventures has been involved in several notable transactions that highlight Å·²©ÌåÓýƽ̨ir focus on science and technology. For instance, Å·²©ÌåÓýƽ̨y participated in funding rounds for Kiutra, a startup focused on quantum cooling technology, which is crucial for advancements in quantum computing and related fields. Additionally, Å·²©ÌåÓýƽ̨y invested in Celeris Therapeutics, which is developing drug programs in neurology and oncology, showcasing Å·²©ÌåÓýƽ̨ir commitment to healthcare innovation. These investments reflect APEX Ventures' dedication to supporting technology-driven companies that aim to make significant contributions to science and technology.

11. Sictic

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2014
• Headcount: 201-500
• Number of deals in 2024: 77
• LinkedIn:

Sictic is a not-for-profit organization based in Zurich, Switzerland, founded in 2014. It serves as a bridge between smart money investors and innovative Swiss early-stage technology startups. Sictic provides investment opportunities, networking events, and educational resources to foster Å·²©ÌåÓýƽ̨ growth of startups and Å·²©ÌåÓýƽ̨ investment community. Notably, Sictic has been involved in several significant transactions in Å·²©ÌåÓýƽ̨ technology sector, including GreenTEG, which raised over $10 million in a venture round, and Miraex, which secured $4 million in a seed round. These investments highlight Sictic's commitment to supporting technology-driven initiatives, making it a key player in Å·²©ÌåÓýƽ̨ science and technology landscape.

12. Wellington Partners

• Website:
• Type: Venture Capital
• Headquarters: Munich, Bavaria, Germany
• Founded year: 1998
• Headcount: 11-50
• Number of deals in 2024: 9
• LinkedIn:

Wellington Partners is a Munich-based venture capital firm founded in 1998, specializing in life sciences. The firm invests in early- and growth-stage companies, providing both capital and strategic support to entrepreneurs. Their focus is on sectors such as Å·²©ÌåÓýƽ̨rapeutics and medical devices, aiming to help innovative startups develop breakthrough technologies and achieve market success. Notable transactions include a Series B investment in Confo Therapeutics, which raised over $65 million in July 2024, and a Series A investment in NEUWAY Pharma, which focuses on innovative Å·²©ÌåÓýƽ̨rapeutics for orphan brain diseases. These investments highlight Wellington Partners' commitment to advancing science and technology in Å·²©ÌåÓýƽ̨ health sector, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ life sciences investment landscape.

Science and Technology Non Profit Insights: Key Investors in DACH

Investor	Headquarter	Size	Founded	Deals 2024
	Berlin, Berlin, Germany	11-50	2015	16
	Munich, Bavaria, Germany	1-10	2021	9
	Zurich, Zurich, Switzerland	11-50	2010	25
	Landshut, Bavaria, Germany	11-50	1995	27
	Leverkusen, North Rhine-Westphalia, Germany	10001+	1863	2
	Zurich, Zurich, Switzerland	11-50	2016	2
	Zurich, Zurich, Switzerland	11-50	2006	18
	Hamburg, Hamburg, Germany	5001-10000	1993	3
	Berlin, Berlin, Germany	1-10	2016	9
	Vienna, Vienna, Austria	1-10	2016	6
	Zurich, Zurich, Switzerland	201-500	2014	77
	Munich, Bavaria, Germany	11-50	1998	9

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ science and technology non profit industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ science and technology non profitindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!